Compare Cassava Sciences Inc (FLNA) vs iShares Global Clean Energy ETF (ICLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs iShares Global Clean Energy ETF — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while iShares Global Clean Energy ETF trades at $18.44. The key difference: iShares Global Clean Energy ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | ICLN | |
|---|---|---|
Market Cap | $53.14M | — |
Sector | Health | — |
52-Week High | $4.64 | $23.75 |
52-Week Low | $1.09 | $13.41 |
Enterprise Value | -$33.43M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
ICLN is trading at $18.65, down 2.2% today amid bearish technical signals with 14 sell indicators versus 4 buy signals. The ETF has shown strong performance in 2026 with a 29% YTD return, outperforming the S&P 500, driven by AI momentum and high global energy prices. Recent news highlights clean energy sector strength with multiple ETF comparisons showing ICLN's competitive positioning against traditional energy and infrastructure funds.
The outlook remains cautiously optimistic as clean energy benefits from structural tailwinds including data center demand and global energy security concerns. Key risks include regulatory uncertainty from stalled US permits threatening $121 billion in investment and geopolitical tensions affecting Chinese solar manufacturers. Analyst sentiment appears mixed with some viewing the recent pullback as a buying opportunity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About iShares Global Clean Energy ETF
The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.
Read more on ICLN →
